(Q38209604)

31 August 2017

title

CXCL12-CXCR4 contributes to the implication of bone marrow in cancer metastasis (English)

1 reference

31 August 2017

1 reference

Jingsheng Shi

1

1 reference

31 August 2017

Yibing Wei

2

1 reference

31 August 2017

Jun Xia

3

1 reference

31 August 2017

Siqun Wang

4

1 reference

31 August 2017

Jianguo Wu

5

1 reference

31 August 2017

Feiyan Chen

6

1 reference

31 August 2017

Gangyong Huang

7

1 reference

31 August 2017

Jie Chen

8

1 reference

31 August 2017

language of work or name

English

0 references

publication date

1 April 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

10

1 reference

31 August 2017

issue

5

1 reference

31 August 2017

page(s)

749-759

1 reference

Chemokines and their receptors in the central nervous system

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CXCR4-targeted therapy inhibits VEGF expression and chondrosarcoma angiogenesis and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CXCR4 stimulates macropinocytosis: implications for cellular uptake of arginine-rich cell-penetrating peptides and HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CXCL12 (SDF-1)/CXCR4 pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CXCL12/CXCR4 signaling in the osteoblast regulates the mesenchymal stem cell and osteoclast lineage populations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

A review on CXCR4/CXCL12 axis in oncology: no place to hide.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

New insight into the SDF-1/CXCR4 axis in a breast carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Concise review: Current concepts in bone marrow microenvironmental regulation of hematopoietic stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Endothelial and perivascular cells maintain haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

The vascular niche: home for normal and malignant hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

The stem cell niches in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

The prostate cancer bone marrow niche: more than just 'fertile soil'.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Bone marrow microenvironment and tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

The hematopoietic stem cell and its niche: a comparative view

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Niche-to-niche migration of bone-marrow-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

The niche as a target for hematopoietic manipulation and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Bone marrow cells in the 'pre-metastatic niche': within bone and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Role of macrophage polarization in tumor angiogenesis and vessel normalization: implications for new anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Evaluation of angiogenesis using micro-computed tomography in a xenograft mouse model of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Hypoxia-induced angiogenesis: good and evil

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

The multifaceted circulating endothelial cell in cancer: towards marker and target identification.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Tumour vascularization: sprouting angiogenesis and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

The role of hypoxia-induced factors in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CXCR4 inhibitors: tumor vasculature and therapeutic challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CXCR4 regulates growth of both primary and metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

A proinflammatory cytokine inhibits p53 tumor suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Soluble mediators of inflammation during tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Tumour necrosis factor-alpha as a tumour promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CTLA-4 blockade increases IFNgamma-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

The chemokine stromal cell-derived factor-1 alpha modulates alpha 4 beta 7 integrin-mediated lymphocyte adhesion to mucosal addressin cell adhesion molecule-1 and fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Inhibition of stromal CXCR4 impairs development of lung metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Small molecule inhibitors of CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Molecular mechanisms underlying the role of microRNAs in resistance to epidermal growth factor receptor-targeted agents and novel therapeutic strategies for treatment of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Bone Metastases: Molecular Mechanisms and Novel Therapeutic Interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.193

21 January 2018

Identifiers

DOI

10.2217/FON.13.193

1 reference

31 August 2017

1 reference